Headache Journal
Become a Member Member Login

2023 Resident Education Program

Start Date: 10/13/2023
End Date: 10/15/2023
Location: In-person Event - UCLA Meyer and Renee Luskin Conference Center Los Angeles, CA

Add to Google Calendar

Overview

The Resident Education Program aims to provide early-stage adult and pediatric neurology residents (and other residency programs) with a foundation in headache medicine education led by experienced faculty in neurologic education and headache medicine.

We hope that this program will inspire a greater number of junior neurology trainees to consider pursuing careers in headache medicine.

 

Program Details

This fall, the American Headache Society’s Resident Education Program will be held in-person starting the evening of Friday, October 13 through the morning of Sunday, October 15, 2023 in Los Angeles, CA.

Faculty and residents will engage throughout the meeting in an interactive format that features lectures, small group sessions and workshops, and a friendly competition, as well as informally at combined faculty-resident meals and social events.

The Resident Education Program will:

  • Provide early stage adult and pediatric neurology residents with a foundation in headache medicine education.
  • Promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders.
  • Introduce residents to experienced faculty in neurologic education and headache medicine.
  • Inspire a greater number of neurology residents to pursue careers in headache medicine.

Residents who participate in the Resident Education Program will be prepared to:

  • Diagnose and manage patients consulting for headache conditions, including the evidence-based use of pharmacologic, nonpharmacologic, procedural, and behavioral approaches
  • Differentiate where and how new therapies augment and improve the current standard of care in the acute and preventive treatment of migraine and other headache disorders
  • Engage in scholarly activity about migraine (e.g. teaching, research)

 

Health and Safety Policy

The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.

Program Committee

Matthew S. Robbins, MD, FAHS, Chair

Weill Cornell Medical College
New York, NY

Deborah I. Friedman, MD, MPH, FAHS

UT Southwestern
Dallas, TX

Amy Gelfand, MD, MAS, FAHS

University of California San Francisco
San Francisco, CA

Peter J. Goadsby, MD, PhD, FAHS

University of California, Los Angeles
Los Angeles, CA

Melissa Rayhill, MD, FAHS

University at Buffalo Jacobs School of Medicine, The State University of New York
Williamsville, NY

Noah Rosen, MD, FAHS

Donald and Barbara Zucker School of Medicine Northwell Headache Center
Great Neck, NY

Niushen Zhang, MD, FAHS

Stanford University
Palo Alto, CA